Government of India will partner with Coalition for Epidemic Preparedness Innovations (CEPI) and pharma company Panacea Biotec, for developing a new Covid Vaccine.

Highlights

  • They will develop vaccine candidates to provide broad protection against SARS-COV-2 variants as well as other beta coronaviruses.
  • CEPI’ll be partnering with a consortium comprising of Translational Health Science and Technology Institute (THSTI) which is an autonomous institute of Department of Biotechnology under Ministry of Science and Technology and Panacea Biotec.

Development ofMulti-epitope
CEPI’ll provide funding of over to USD 12 million for supporting the development ofmulti-epitope, advance manufacturing process and nanoparticle- based vaccine candidates.
For this, lead antigen will be designed and named through evidence-of- conception preclinical studies. Following this, CEPI’ll undertake initial clinical development through Phase 1 or 2 of studies.
Blueprint Priority Conditions
WHO’s blueprint priority diseases include

  1. Middle East respiratory syndrome- related coronavirus (MERS-CoV)
  2. Severe acute respiratory pattern coronavirus 2 (SARS-CoV-2)
  3. Nipah virus
  4. Lassa fever virus
  5. Rift Valley fever virus
  6. Chikungunya virus and
  7. Gypothetical, unknown pathogen “ Disease X”.

Related Articles

IBPS CRP-Clerks-XII Result 2023 announced on ibps.in; download here

IBPS CRP-Clerks-XII Result 2023: IBPS (Institute of Banking Personnel Selection) has released the results of the online main examination for CRP-Clerks-XII. Candidates who appeared for the exam can now view their result status on the official IBPS website -...

IBPS Clerk Mains Result 2022 declared at ibps.in, direct link here

Institute of Banking Personnel Selection has declared IBPS Clerk Mains Result 2022 on April 1, 2023. Candidates who have appeared for CRP CLERKS-XII main examination can check their results through the official site of IBPS at ibps.in. IBPS Clerk Mains Result...